Added by |
liaudet-coopman |
Group name |
EquipeELC |
Item Type |
Journal Article |
Title |
Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations? |
Creator |
Jacot et al. |
Author |
William Jacot |
Author |
Charles Theillet |
Author |
Séverine Guiu |
Author |
Pierre-Jean Lamy |
Publication |
Future Oncology (London, England) |
Volume |
11 |
Issue |
4 |
Pages |
557-559 |
Date |
2015 |
Journal Abbr |
Future Oncol |
Language |
eng |
DOI |
10.2217/fon.14.268 |
ISSN |
1744-8301 |
Short Title |
Targeting triple-negative breast cancer and high-grade ovarian carcinoma |
Library Catalog |
PubMed |
Extra |
PMID: 25686112 |
Tags |
53BP1, Antineoplastic Agents, BRCA1, breast cancer, clinic, Female, Genes, BRCA1, Genes, BRCA2, Genomic Instability, Humans, Molecular Targeted Therapy, Mutation, Neoplasm Grading, Ovarian Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, targeted therapies, Triple Negative Breast Neoplasms |
Date Added |
2018/09/26 - 14:32:39 |
Date Modified |
2019/05/29 - 12:28:43 |